Register for 2023 HSPS |
|
Log Back In |
|
Keynote Panel
From Burnout to Engagement: Advice for Pharmacy Leaders
|
Disclosure: Dr. Hooper does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Managing Buprenorphine in Hospitalized Patients with Opioid Use Disorder
|
Disclosure: Dr. Janzen does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
New 2022 Advisory Committee on Immunization Practices (ACIP) Recommendations
|
Bridging Anticoagulation in the Perioperative Setting
|
Dr. Wenger grew up in the Chicago suburbs and then moved to Indianapolis, IN to pursue his pharmacy education. He graduated from Butler University College of Pharmacy & Health Sciences in 2020 with a PharmD & Medical Spanish concentration. He then completed a PGY1 residency at Community Health Network in Indianapolis, followed by a PGY2 residency in Pharmacotherapy at Community Health Network & Butler University, where he also served as adjunct faculty. Following his training, Dr. Wenger accepted his current position as a Clinical Assistant Professor of Pharmacy Practice with The University of Texas at Austin College of Pharmacy. He maintains a practice as an Internal Medicine Clinical Pharmacy Specialist at Ascension Seton Medical Center Austin, where he provides clinical pharmacy services on an interdisciplinary academic rounding service to an adult patient population with primarily cardiac disease states. He is passionate about health equity, mentorship, medication access/affordability, and the improvement of patient outcomes through interprofessional care. His current practice & research interests include transitions of care, medication optimization for cardiovascular disease states, LGBTQ+ health, and cultural competency. In his spare time, Dr. Wenger likes to spend time outside in nature, explore the city of Austin, check out new & interesting restaurants, and watch lots of TV shows & movies.
Disclosure: Dr. Wenger does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Phenobarbital for Alcohol Withdrawal in the Non-ICU Setting
|
Texas Pharmacy Law Update - Health Systems Focus
|
Disclosure: Julie Spier does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Building a Well-Rounded Pharmacy Workplace that Fosters Inclusivity and Belonging
|
Tools and Perspectives for Responding to the Drug Shortages
|
New Drug Update - Health Systems Focus
|
Pain Management: Pain Management in the Hospital
|
Looking at Pharmacy Practice Through the Transtions-of-Care Lens
|
Human Trafficking Prevention: Pharmacy Perspective
|
Dr. Ashley Garling graduated Rho Chi with honors from the MCV/Virginia Commonwealth University School of Pharmacy. Her career path went from community pharmacy management, inpatient pharmacy with an oncology focus, to corporate clinical coordinator, and media spokeswoman. She is now a clinical assistant professor at The University of Texas at Austin College of Pharmacy where she serves as a communication, media, and patient engagement specialist. Dr. Garling is the principal investigator (PI) and Co-PI for research projects in community pharmacy settings spanning from telehealth, HIV PrEP, mental health, patient counseling, and medication adherence. She currently serves as president of the Capital Area Pharmacist Association, Affairs Public Policy Council Member, and Public Policy Council Member of the Texas Pharmacist Association. Her career pillars are focused on public activation, empowerment of underheard voices, and health education. In 2020-21, Dr. Garling was awarded the Dr. Carolyn Brown DEAI Champion Award and the 2021 Teaching Excellency Award in recognition of her outstanding contributions to diversity, inclusion, and pharmacy education.
Disclosure: Dr. Garling does not have any relevant financial relationship(s) with ineligible companies (as defined by the Standards for Integrity and Independence).
Sterile Compounding:
797 Updates: 7 Key Takeaways
|
On-demand:
Sterile Compounding: USP <797> Update: A Deeper Dive
|
On-demand:
The Health System Pharmacist Role in Addressing Social Determinants of Health
|
On-demand:
Expanding Opportunities for Pharmacy Technician Professional Development
|
On-demand:
Ramadan: Cultural Impact on Patient Care
|
Precepting Resident Students
|
Prescribing and Monitoring Controlled Substances: 2022 CDC Guideline for Prescribing Opioids for Pain
|
Mental Health Awareness: Treatment Update on Obsessive Compulsive Disorder
|
Stigma Kills - Addressing Opioid and Substance Use Disorder by Changing Health System Culture
|
On-demand: - DELAYED
The Future of Contraceptive Care
|
Overall Evaluation
|